Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation

Peer Review reports

Original Submission
24 Jun 2011	Submitted	Original manuscript
12 Jul 2011	Reviewed	Reviewer Report - Oliver Stoeltzing
4 Aug 2011	Reviewed	Reviewer Report - Chann Lagadec
30 Sep 2011	Author responded	Author comments - Jessica Bohonowych
Resubmission - Version 2
30 Sep 2011	Submitted	Manuscript version 2
21 Oct 2011	Reviewed	Reviewer Report - Oliver Stoeltzing
15 Nov 2011	Author responded	Author comments - Jessica Bohonowych
Resubmission - Version 3
15 Nov 2011	Submitted	Manuscript version 3
Publishing
15 Dec 2011	Editorially accepted
15 Dec 2011	Article published	10.1186/1471-2407-11-520

Back to article page